About Promaxo
Promaxo is a company based in Rockville (United States) founded in 2016 by Irving Weinberg, Michael Bartholomew, and Amit Vohra. Promaxo has raised $99.13 million across 13 funding rounds from investors including Zepp, MicroPort Orthopedics and TEDCO. The company has 22 employees as of December 31, 2021. Promaxo offers products and services including Promaxo MRI System. Promaxo operates in a competitive market with competitors including Openwater, Hyperfine, InkSpace Imaging, MRIguidance and Fonar, among others.
- Headquarter Rockville, United States
- Employees 22 as on 31 Dec, 2021
- Founders Irving Weinberg, Michael Bartholomew, Amit Vohra
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Promaxo, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$99.13 M (USD)
in 13 rounds
-
Latest Funding Round
$26.85 M (USD), Series C
Mar 17, 2026
-
Investors
Zepp
& 8 more
-
Employee Count
22
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Promaxo
Promaxo offers a comprehensive portfolio of products and services, including Promaxo MRI System.
Enables in-office MRI-guided prostate biopsies and cancer detection.
People of Promaxo
Unlock access to complete
Unlock access to complete
Funding Insights of Promaxo
Promaxo has successfully raised a total of $99.13M across 13 strategic funding rounds. The most recent funding activity was a Series C round of $26.85 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Promaxo
Promaxo has secured backing from 9 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Zepp, MicroPort Orthopedics and TEDCO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Zynext Ventures is focused on funding disruptive healthcare innovations.
|
Locked | Locked | Locked | |
|
MedTech Venture Partners is focused on medical technology investments.
|
Locked | Locked | Locked | |
|
Almond Tree Capital is focused on accelerating MedTech companies.
|
Locked | Locked | Locked |
Investor details for Promaxo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Promaxo
Investment portfolio details for Promaxo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Promaxo
Detailed financials for Promaxo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Promaxo Comparisons
Peer comparison for Promaxo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Promaxo
Promaxo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Openwater, Hyperfine, InkSpace Imaging, MRIguidance and Fonar, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of imaging technologies for medical diagnosis and treatments
|
|
| Locked | Locked | Locked |
Portable MRI systems are manufactured for medical professionals.
|
|
| Locked | Locked | Locked |
Patented customized MRI coils are developed for pediatric applications.
|
|
| Locked | Locked | Locked |
An MRI-based platform for bone diagnostics is provided.
|
|
| Locked | Locked | Locked |
Upright multi-position MRI systems are developed for disease diagnostics.
|
Detailed competitors of Promaxo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Promaxo
Complete news archive for Promaxo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Promaxo
Promaxo was founded in 2016.
Promaxo is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
Amit Vohra is the current CEO of Promaxo. They have also founded this company.
Promaxo is a funded company, having raised a total of $99.13M across 13 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Promaxo is 22.
The company was founded in 2016 in Rockville, United States, within the medical imaging sector. Portable MRI systems targeted at cancer diagnostics are produced, with a focus on prostate applications. Imaging data for prostate scans is collected and analyzed through the platform technology, achieving results in less time than traditional MRIs. Initial use involves screening patients with elevated PSA levels to evaluate biopsy requirements.
Promaxo offers Promaxo MRI System.
Promaxo has 9 investors. Key investors include Zepp, MicroPort Orthopedics, TEDCO, Zynext Ventures, and Fred Moll.